MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on April 13

Rhea-AI Summary

MedAvail Holdings, Inc. (Nasdaq: MDVL) is set to announce its financial results for the fourth quarter and full year ended December 31, 2022, on April 13, 2023, after market close. The management will host a conference call and webcast at 4:30 PM EDT to discuss these results. Investors can join the call via a dedicated dial-in number or by accessing the live audio webcast through MedAvail's investor relations website. MedAvail specializes in pharmacy technology, providing in-clinic pharmacy services through its MedCenter robotic dispensing platform, aiming to enhance drug adherence and health outcomes for patients.

Positive

• Upcoming financial results announcement may reflect operational improvements.
• Management engagement through a conference call may boost investor confidence.

Negative

• None.

Management to host investor conference call and webcast at 4:30pm EDT on that day

PHOENIX, April 12, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today announced that the Company will announce financial results for the fourth quarter and full-year ended December 31, 2022, on Thursday, April 13^th, after the close of the financial markets.  MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Call and webcast details:
Thursday, April 13^th, 2023 @ 4:30pm ET
Investor dial-in: 1-877-704-4453 (domestic) or 1-201-389-0920 (international)
Conference ID: 13737951
To access the Call me™ feature, which avoids having to wait for an operator, click here.

The live audio webcast can be accessed by registering online on the “Investor Relations” section of MedAvail’s website at: https://investors.medavail.com. The webcast will be archived and available for replay after the event.

About MedAvail
MedAvail Holdings, Inc. (NASDAQ: MDVL) is a pharmacy technology company, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com.

Contacts:

Investor Relations
Steven Halper/Caroline Paul
Managing Directors, LifeSci Advisors
ir@medavail.com

SOURCE MedAvail Holdings, Inc.

 

FAQ

When will MedAvail announce its fourth-quarter financial results for 2022?

MedAvail will announce its financial results on April 13, 2023, after market close.

What time is MedAvail's investor conference call scheduled?

The investor conference call is scheduled for 4:30 PM EDT on April 13, 2023.

How can I access the MedAvail conference call?

Investors can dial in at 1-877-704-4453 (domestic) or 1-201-389-0920 (international) to access the call.

What is MedAvail's primary business focus?

MedAvail focuses on innovative pharmacy technology, providing in-clinic pharmacy services through its robotic dispensing platform.

Where can I find the archived webcast of the MedAvail conference call?

The archived webcast will be available on MedAvail's investor relations website after the event.